Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Share-based Compensation: 2013-2018

Historic Share-based Compensation for Armata Pharmaceuticals (ARMP) over the last 5 years, with Dec 2018 value amounting to -$1,000.

  • Armata Pharmaceuticals' Share-based Compensation fell 100.76% to -$1,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $142,000, marking a year-over-year decrease of 79.71%. This contributed to the annual value of $2.9 million for FY2024, which is 208.42% up from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Share-based Compensation of -$1,000 as of Q4 2018, which was down 112.50% from $8,000 recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year Share-based Compensation high stood at $1.4 million for Q3 2014, and its period low was -$1,000 during Q4 2018.
  • Over the past 3 years, Armata Pharmaceuticals' median Share-based Compensation value was $151,500 (recorded in 2017), while the average stood at $236,417.
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 1,469.23% in 2016, then crashed by 100.76% in 2018.
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' Share-based Compensation stood at $61,000 in 2014, then skyrocketed by 277.05% to $230,000 in 2015, then grew by 29.13% to $297,000 in 2016, then slumped by 55.56% to $132,000 in 2017, then plummeted by 100.76% to -$1,000 in 2018.
  • Its Share-based Compensation was -$1,000 in Q4 2018, compared to $8,000 in Q3 2018 and $13,000 in Q2 2018.